GSK takes over Novartis' troubled OTC plant; China wants drug distribution reforms;

> GlaxoSmithKline ($GSK) now has control of the troubled Novartis ($NVS) OTC plant in Lincoln, NE, as part of their new consumer health JV. Story

> Mapi Group has added pharma regulatory consulting services, CanReg Group, after its acquisition this year of the North American and European regulatory consulting services of Optum Life Sciences. Release

> China's government is suggesting drugmakers cut middlemen out of the processing selling their drugs in an effort to cut costs and reduce corruption. Story